Paper Details

  1. Home
  2. Paper Details

Effectiveness of ledipasvir/sofosbuvir in real-world patients with chronic hepatitis C: a collaborative treatment approach.

Author: AmmiratiShelby R, DarnellTimothy A, HartisCharles E, JohnsonSteven W, MorganMichael R, PriestDavid H, SchmidlinHolly N, SilwalAdwait, WeberStephen F

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Observational StudyResearch that observes and collects data on participants' behavior and outcomes in their natural state, without intervention.

Overview

This study evaluated the effectiveness of ledipasvir/sofosbuvir (LDV/SOF) in treating chronic hepatitis C virus (HCV) in routine clinical practice. The results show that LDV/SOF, when used as part of a standardized interprofessional treatment protocol, is associated with high sustained virological response (SVR) rates and good tolerability.
Paper Details　
Original Abstract of the Article :
The effectiveness of ledipasvir/sofosbuvir (LDV/SOF) in routine use in clinical practice for the management of chronic hepatitis C virus (HCV) has not been well described. Data with prior agents suggest that management of HCV using an interprofessional approach in clinical practice is associated wit...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.ijantimicag.2017.01.016

データ提供：米国国立医学図書館（NLM）

Ledipasvir/Sofosbuvir: A Collaborative Approach to Hepatitis C Treatment

The medical community is constantly seeking effective treatments for chronic hepatitis C virus (HCV) infection. This study investigates the effectiveness of ledipasvir/sofosbuvir (LDV/SOF) in a real-world clinical setting. The researchers utilized a collaborative, interprofessional approach to managing HCV patients, and their findings are encouraging. They observed a high sustained virological response (SVR) rate, indicating successful treatment outcomes. Additionally, the treatment was well-tolerated, with minimal adverse effects. This study underscores the importance of a collaborative approach to HCV treatment, leading to improved patient outcomes.

Ledipasvir/Sofosbuvir: A Collaborative Success Story

This study reveals that ledipasvir/sofosbuvir, when administered within a collaborative treatment approach, can effectively manage chronic hepatitis C virus infection. The high SVR rate and minimal adverse effects are promising indicators of the drug's effectiveness and safety. This research underscores the benefits of collaborative healthcare models in achieving optimal treatment outcomes for HCV patients.

Collaboration: The Key to Hepatitis C Treatment

The success of ledipasvir/sofosbuvir in this study emphasizes the crucial role of collaboration in managing chronic hepatitis C virus infection. This research suggests that a collaborative approach can optimize treatment outcomes, leading to better patient experiences and improved overall healthcare delivery. This collaborative approach can be implemented in other areas of healthcare to improve patient care and achieve better results.

Dr.Camel's Conclusion

Imagine a vast desert of hepatitis C infection where a collaborative oasis of healthcare professionals emerges, offering a lifeline of effective treatment. The study's findings demonstrate the power of collaboration in managing HCV infection, creating a path towards a healthier future for patients.

Date :
  1. Date Completed 2018-02-20
  2. Date Revised 2020-12-09
Further Info :

Pubmed ID

28389353

DOI: Digital Object Identifier

10.1016/j.ijantimicag.2017.01.016

Related Literature

Article Analysis
・Side Effects of ledipasvir and sofosbuvir
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.